First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Kathy Monteith; Lisa McSweeney; Colm R.  Breathnach; Lucy  Sherrin; Patrick Dicker; Elizabeth C.  Tully; John  O'Loughlin; Sharon Campbell; Greg Byrne; Fergal D. Malone; Afif El-Khuffash; Etaoin Kent; Ann Doherty

doi:10.21427/09py-bc22

First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Kathy Monteith
, Lisa McSweeney
, Colm R. Breathnach
, Lucy Sherrin
, Patrick Dicker
, Elizabeth C. Tully
, John O'Loughlin
, Sharon Campbell
, Greg Byrne
, Fergal D. Malone
, Afif El-Khuffash
, Etaoin Kent
, Ann Doherty

School of Biological, Health and Sports Sciences

Research output: Contribution to conference › Poster › peer-review

Abstract

To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).

Original language	English
Pages	S207-S207
DOIs	https://doi.org/10.21427/09py-bc22 https://doi.org/10.1016/j.ajog.2017.10.267
Publication status	Published - 1 Jan 2018

Keywords

non-invasive cardiac output monitoring
NICOM
non-invasive maternal hemodynamic assessment
bioreactance
first trimester biomarkers
gestational hypertension
GH
pre-eclampsia
PE
normotensive fetal growth restriction
FGR

Access to Document

10.21427/09py-bc22Licence: CC BY-NC-SA
10.1016/j.ajog.2017.10.267

Cite this

Monteith, K., McSweeney, L., Breathnach, C. R., Sherrin, L., Dicker, P., Tully, E. C., O'Loughlin, J., Campbell, S., Byrne, G., Malone, F. D., El-Khuffash, A., Kent, E., & Doherty, A. (2018). First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study. S207-S207. https://doi.org/10.21427/09py-bc22, https://doi.org/10.1016/j.ajog.2017.10.267

@conference{ee0ab0ac5b9e4456a967ff3a1103804b,

title = "First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study",

abstract = "To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).",

keywords = "non-invasive cardiac output monitoring, NICOM, non-invasive maternal hemodynamic assessment, bioreactance, first trimester biomarkers, gestational hypertension, GH, pre-eclampsia, PE, normotensive fetal growth restriction, FGR",

author = "Kathy Monteith and Lisa McSweeney and Breathnach, \{Colm R.\} and Lucy Sherrin and Patrick Dicker and Tully, \{Elizabeth C.\} and John O'Loughlin and Sharon Campbell and Greg Byrne and Malone, \{Fergal D.\} and Afif El-Khuffash and Etaoin Kent and Ann Doherty",

year = "2018",

month = jan,

day = "1",

doi = "10.21427/09py-bc22",

language = "English",

pages = "S207--S207",

}

TY - CONF

T1 - First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

AU - Monteith, Kathy

AU - McSweeney, Lisa

AU - Breathnach, Colm R.

AU - Sherrin, Lucy

AU - Dicker, Patrick

AU - Tully, Elizabeth C.

AU - O'Loughlin, John

AU - Campbell, Sharon

AU - Byrne, Greg

AU - Malone, Fergal D.

AU - El-Khuffash, Afif

AU - Kent, Etaoin

AU - Doherty, Ann

PY - 2018/1/1

Y1 - 2018/1/1

N2 - To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).

AB - To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).

KW - non-invasive cardiac output monitoring

KW - NICOM

KW - non-invasive maternal hemodynamic assessment

KW - bioreactance

KW - first trimester biomarkers

KW - gestational hypertension

KW - GH

KW - pre-eclampsia

KW - PE

KW - normotensive fetal growth restriction

KW - FGR

U2 - 10.21427/09py-bc22

DO - 10.21427/09py-bc22

M3 - Poster

SP - S207-S207

ER -

First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Abstract

Keywords

Access to Document

Fingerprint

Cite this